Aclarion Ownership
| ACON Stock | USD 7.12 0.29 3.91% |
Shares in Circulation | First Issued 2020-03-31 | Previous Quarter 1.4 K | Current Value 200 | Avarage Shares Outstanding 282.8 K | Quarterly Volatility 1.2 M |
Aclarion Stock Ownership Analysis
The company has price-to-book (P/B) ratio of 0.28. Some equities with similar Price to Book (P/B) outperform the market in the long run. Aclarion recorded a loss per share of 11.5. The entity had not issued any dividends in recent years. The firm had 1:27 split on the 28th of March 2025. Aclarion, Inc., a healthcare technology company, develops software application for magnetic resonance spectroscopy in the United States. Aclarion, Inc. was founded in 2008 and is based in San Mateo, California. Aclarion operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 3 people. For more info on Aclarion please contact Brent Ness at 833 275 2266 or go to https://www.aclarion.com.Aclarion Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Aclarion is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Aclarion backward and forwards among themselves. Aclarion's institutional investor refers to the entity that pools money to purchase Aclarion's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Ubs Group Ag | 2025-03-31 | 52.0 | Morgan Stanley - Brokerage Accounts | 2025-03-31 | 5.0 | Bank Of America Corp | 2025-03-31 | 4.0 | Tower Research Capital Llc | 2025-03-31 | 3.0 | Clear Street Llc. | 2025-03-31 | 3.0 | Susquehanna International Group, Llp | 2024-12-31 | 0.0 | Jane Street Group Llc | 2024-12-31 | 0.0 |
Aclarion Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Aclarion insiders, such as employees or executives, is commonly permitted as long as it does not rely on Aclarion's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Aclarion insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Neal David K over three months ago Disposition of 152128 shares by Neal David K of Aclarion subject to Rule 16b-3 | ||
Deitsch Stephen over three months ago Acquisition by Deitsch Stephen of 63000 shares of Aclarion subject to Rule 16b-3 | ||
Deitsch Stephen over six months ago Acquisition by Deitsch Stephen of 63000 shares of Aclarion subject to Rule 16b-3 | ||
Neal David K over six months ago Disposition of 66934 shares by Neal David K of Aclarion at 1.94 subject to Rule 16b-3 | ||
Neal David K over a year ago Disposition of 3347 shares by Neal David K of Aclarion at 1.34 subject to Rule 16b-3 | ||
Ryan Bond over a year ago Purchase by Ryan Bond of 20000 shares of Aclarion | ||
Thramann Jeffrey John over a year ago Purchase by Thramann Jeffrey John of tradable shares of Aclarion |
Aclarion Outstanding Bonds
Aclarion issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Aclarion uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Aclarion bonds can be classified according to their maturity, which is the date when Aclarion has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Aclarion Corporate Filings
| 18th of July 2025 Other Reports | ViewVerify | |
8K | 7th of July 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
| 26th of June 2025 Other Reports | ViewVerify | |
| 17th of June 2025 Other Reports | ViewVerify |
Pair Trading with Aclarion
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Aclarion position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aclarion will appreciate offsetting losses from the drop in the long position's value.Moving against Aclarion Stock
| 0.64 | EW | Edwards Lifesciences Corp Earnings Call This Week | PairCorr |
| 0.54 | DXCM | DexCom Inc Earnings Call This Week | PairCorr |
| 0.4 | LH | Laboratory Earnings Call This Week | PairCorr |
| 0.34 | OM | Outset Medical | PairCorr |
The ability to find closely correlated positions to Aclarion could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Aclarion when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Aclarion - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Aclarion to buy it.
The correlation of Aclarion is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Aclarion moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Aclarion moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Aclarion can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aclarion. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. To learn how to invest in Aclarion Stock, please use our How to Invest in Aclarion guide.You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aclarion. If investors know Aclarion will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aclarion listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (11.50) | Revenue Per Share | Quarterly Revenue Growth 0.878 | Return On Assets | Return On Equity |
The market value of Aclarion is measured differently than its book value, which is the value of Aclarion that is recorded on the company's balance sheet. Investors also form their own opinion of Aclarion's value that differs from its market value or its book value, called intrinsic value, which is Aclarion's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aclarion's market value can be influenced by many factors that don't directly affect Aclarion's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aclarion's value and its price as these two are different measures arrived at by different means. Investors typically determine if Aclarion is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aclarion's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.